Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. New research suggests that the casirivimab-imdevimab monoclonal antibody treatment for COVID-19 ...

As the number of coronavirus cases increases, again, there's high demand for emergency-use monoclonal antibodies that successfully combat COVID-19. Casirivimab, imdevimab bamlanivimab, etesevimab and ...

As we prepare for the festive season, it’s easy to let COVID boosters fall off our to-do lists. But COVID is still circulating and new shots are available.

(Reuters) - The U.S. Food and Drug Administration (FDA) on Tuesday granted emergency-use authorization to Inflarx NV's monoclonal antibody for the treatment of hospitalized COVID patients when ...

The regional infusion center for Southeast Texas has received a new federal notice, which will force the center to further restrict the patients who may receive the potentially-lifesaving COVID ...

The FDA issued an emergency use authorization (EUA) for pemivibart (Pemgarda) as COVID-19 pre-exposure prophylaxis in immunocompromised individuals who are unlikely to mount a sufficient immune ...

Data supporting antibodies is limited compared to that for authorized vaccines. Despite more than 187 million Americans being fully vaccinated against COVID-19 and data and attestations from ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. CLEVELAND, Ohio (KFOR/Storyful) – Desperate ...

Early studies hint that a nerve block in the neck could help restore long COVID patients' sense of smell, but more research is needed. When you purchase through links on our site, we may earn an ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Overall, 22 of 37 participants reported improved ...